Dr. La Torre’s laboratory focuses on generating retinal ganglion cells from stem cells to enhance axonal growth and cell survival and ultimately, to use these cells as donor cells for cell replacement therapies.
Read More »
The 2020 Weston Lecture featured a talk by world-renowned Harvard Medical School genetics researcher and best-selling author David Sinclair, PhD, AO.
Read More »This recorded 45-minute webinar features a presentation from Anna La Torre, PhD, a principal investigator in the Catalyst for a Cure research consortium.
Read More »
The Catalyst for a Cure Vision Restoration Team report on their latest challenges and progress to date.
Read More »
In this video interview, Anna La Torre, PhD discusses the Catalyst for a Cure Vision Restoration Initiative funded by Glaucoma Research Foundation.
Read More »
The goal of the Catalyst for a Cure Vision Restoration Initiative is to come up with a novel strategy to save or replace lost retinal nerve cells and reconnect them to the brain.
Read More »
Glaucoma Research Foundation awards annual research grants for creative pilot projects that hold promise.
Read More »
The Shaffer Prize, presented annually by Glaucoma Research Foundation during their annual Glaucoma 360 Gala, recognizes a researcher whose project best exemplifies the pursuit of innovative ideas in the quest to better understand glaucoma.
Read More »Dr. Pickering delivered the Weston Glaucoma Research Lecture “A New Era for Glaucoma” October 22, 2019 in Palo Alto, California.
Read More »
Glaucoma Research Foundation launched the Catalyst for a Cure Vision Restoration Initiative to better understand what causes vision loss in glaucoma and then to identify targeted interventions.
Read More »
